FDA approves new breast imaging technology


The U.S. regulator clears GE Heathcare's (GE) Invenia ABUS, a 3D ultrasound technology that enables clinicians to find ~36% more cancers in women with dense breast tissue. The system can scan in as little as 15 minutes using features that conform to a woman's body providing a more enhanced image.

Approximately 40% of women have dense breast tissue. They have a greater risk of developing breast cancer.

From other sites
Comments (5)
  • U2A Ventures
    , contributor
    Comments (344) | Send Message
     
    Great job with this technology $GE!
    3 Jun 2014, 10:16 AM Reply Like
  • solite
    , contributor
    Comment (1) | Send Message
     
    maybe if this was available six years ago, Leslie would be alive and helping people to see the beauty in this day
    3 Jun 2014, 11:16 AM Reply Like
  • reurk
    , contributor
    Comments (46) | Send Message
     
    Leslie who
    3 Jun 2014, 11:21 AM Reply Like
  • donnugent
    , contributor
    Comments (29) | Send Message
     
    Fifteen minutes seems quite long for one scan of breast tissue. I would have thought a scan would take 1.5 minutes.
    3 Jun 2014, 11:33 AM Reply Like
  • bobknight33
    , contributor
    Comment (1) | Send Message
     
    I work as a Ultrasound Field service engineer for GE Healthcare and this is a great leap forward in woman's care. Fantastic product.
    3 Jun 2014, 03:24 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs